Skip to main content
. 2021 Apr 9;7(4):338–349. doi: 10.1002/cjp2.210

Table 1.

Association of patient factors with engraftment.

Factor No. of Samples Engrafted (%) No. of Engrafted Odds Ratio (95% CI) P
Age (years)
<12 36 30.6 11
≥12 32 59.4 19 3.88 (1.1–14.3) 0.042
Tumor type
All 68 44.1 30
Ewing sarcoma 41 41.5 17
Osteosarcoma 12 41.7 5 0.99 (0.2–5.6) *
Rhabdomyosarcoma 15 53.3 8 1.97 (0.4–10.7) * 0.69
Alveolar 9 66.7 6
Embryonal 6 33.3 2
Timing of surgery
Diagnosis 31 22.6 7
Relapse 37 62.2 23 15.4 (1.3–182.8) 0.031
Biopsy origin
Limbs 22 31.8 7
Head and neck 14 64.3 9 21.1 (0.04–11 056.5)
Chest wall and ribs 7 42.9 3 3.4 (0.05–215.9)
Lung or pleura 13 61.5 8 15 (0.07–3,075.8)
Pelvic bones 3 33.3 1 1.2 (0.01–134.4) 0.17
Muscle 2 100 2
Testes 1 0 0
Vertebral spine 6 0 0
Metastasis at diagnosis
No 48 37.5 18
Yes 20 60.0 12 3.62 (0.64–20.50) 0.15
*

Compared to Ewing sarcoma.

Compared to limbs.

Excluded from statistical analysis of biopsy origin due to lack of an event in the number of engrafted or nonengrafted samples.